Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Investigation

• Publication date

  2010-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/07357900902744494PMID 19863350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk factors

  2018cited by this paper
• CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients

  2007cited by this paper
• Functional polymorphism of thymidylate synthase, but not of the COMT and IL‐1B genes, is associated with breast cancer

  2007cited by this paper
• Spectrum of Breast Cancer in Asian Women

  2007cited by this paper
• Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival

  2007cited by this paper
• SNP-SNP interactions in breast cancer susceptibility

  2006cited by this paper
• Polymorphisms in Nucleotide Excision Repair Genes and DNA Repair Capacity Phenotype in Sisters Discordant for Breast Cancer

  2006cited by this paper
• Joint Effects of the CYP1A1 MspI, ERα PvuII, and ERα XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, China

  2006cited by this paper
• Estrogen Metabolism–Related Genes and Breast Cancer Risk: The Multiethnic Cohort Study

  2005cited by this paper
• CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study

  2005cited by this paper
• CYP17 and breast cancer: no overall effect, but what about interactions?

  2005cited by this paper
• Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.

  2005cited by this paper
• Genetic polymorphism of CYP17 and breast cancer risk in Korean women

  2005cited by this paper
• Breast cancer risk associated with genotype polymorphism of the catechol estrogen‐metabolizing genes: A multigenic study on cancer susceptibility

  2005cited by this paper
• Genetic Polymorphisms of SULT1A1 and SULT1E1 and the Risk and Survival of Breast Cancer

  2005cited by this paper
• SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study

  2005cited by this paper
• CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study

  2005cited by this paper
• CYP17 gene polymorphism in relation to breast cancer risk: a case-control study

  2005cited by this paper
• Spectrum of Breast Cancer in Asian Women

  2005cited by this paper
• Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.

  2005cited by this paper
• Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women

  2005cited by this paper
• CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.

  2004cited by this paper
• Genetic Variants of the Sulfotransferase 1A1 and Breast Cancer Risk

  2004cited by this paper
• Estrogen‐metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women

  2004cited by this paper
• Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.

  2004cited by this paper
• UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients

  2004cited by this paper
• Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study

  2004cited by this paper
• Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study

  2004cited by this paper
• The search for low-penetrance cancer susceptibility alleles

  2004cited by this paper
• Combined effect of GSTM1, GSTT1, and COMT genotypes in individual

  2004cited by this paper
• CYP17 & SULT1A1 gene polymorphisms in Indian breast cancer

  2004cited by this paper
• Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.

  2004cited by this paper
• Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women.

  2004cited by this paper
• Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women.

  2003cited by this paper
• Sulfotransferase 1A1 (SULT1A1) Polymorphism, PAH-DNA Adduct Levels in Breast Tissue and Breast Cancer Risk in a Case-Control Study

  2003cited by this paper
• Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study.

  2003cited by this paper
• Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Catecholestrogen sulfation: possible role in carcinogenesis.

  2002cited by this paper
• Polymorphic catechol-O-methyltransferase gene and breast cancer risk.

  2001cited by this paper
• Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.

  2001cited by this paper
• Glutathione S-transferases M1, T1, and P1 and breast cancer.

  2000cited by this paper
• Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

  2000cited by this paper
• Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.

  2000cited by this paper
• CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

  2000cited by this paper
• Chapter 6: Estrogen Metabolism by Conjugation

  2000cited by this paper
• Estrogens as endogenous genotoxic agents--DNA adducts and mutations.

  2000cited by this paper
• Estrogen metabolism by conjugation.

  2000cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

  1999cited by this paper
• Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

  1999cited by this paper
• Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.

  1998cited by this paper
• Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.

  1998cited by this paper
• Association between CYP17 polymorphisms and the development of breast cancer.

  1998cited by this paper
• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cited by this paper
• Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.

  1998cited by this paper
• Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

  1998cited by this paper
• No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.

  1998cited by this paper
• CYP17 genotype and breast cancer risk.

  1998cited by this paper
• Catechol-O-methyltransferase and breast cancer risk.

  1998cited by this paper
• New Role for Estrogen in Cancer?

  1998cited by this paper
• Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

  1998cited by this paper
• Sulfotransferase molecular biology: cDNAs and genes

  1997cited by this paper
• Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype.

  1997cited by this paper
• An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

  1997cited by this paper
• Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.

  1997cited by this paper
• A polymorphism in the CYP17 gene increases the risk of breast cancer.

  1997cited by this paper
• Molecular mechanisms of estrogen carcinogenesis.

  1996influential reference
• Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines.

  1996cited by this paper
• The Relationship between Aryl Hydrocarbon Hydroxylase and Polymorphisms of the CYP1A1 Gene

  1996cited by this paper
• Estrogens and breast cancer.

  1996cited by this paper
• Molecular Mechanisms of Estrogen Carcinogenesis

  1996cited by this paper
• A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.

  1995cited by this paper
• Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

  1994cited by this paper
• Structural characterization of the major adducts formed by reaction of 4,5-epoxy-4,5-dihydro-1-nitropyrene with DNA.

  1991cited by this paper
• PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene.

  1991cited by this paper
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Diesel and Gasoline Engine Exhausts and Some Nitroarenes. Volume 46

  1991cited by this paper
• Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene

  1990cited by this paper
• Gene regulation by steroid hormones.

  1989cited by this paper
• Gene regulation by steroid hormones.

  1987cited by this paper
• Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer.

  1986cited by this paper

• Association of CYP1A1*2A polymorphism and Breast Cancer risk: a meta analysis

  2023influential citation
• Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

  2022cites this paper
• Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women

  2021cites this paper
• The association between CYP17A1, CYP19A1, and HSD17B1 gene polymorphisms of estrogen synthesis pathway and ovarian cancer predisposition

  2021cites this paper
• A meta-analysis and in silico analysis of polymorphic variants conferring breast cancer risk in the Indian subcontinent.

  2020cites this paper
• Association of CYP17 and MTRR Gene Polymorphisms with Clinicopathological Features of Breast Cancer Patients

  2020cites this paper
• Breast cancer susceptibility genes in estrogen metabolizing pathway in a southern Indian population

  2019cites this paper
• Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk

  2018cites this paper
• Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: a Systematic Review and Meta-Analysis

  2017cites this paper
• Impact of Catechol-O-Methyltransferase Val 158Met (rs4680) Polymorphism on Breast Cancer Susceptibility in Asian Population

  2017influential citation
• The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols

  2017influential citation
• POLYMORPHISMS OF ESTROGEN BIOSYNTHESIS AND METABOLIZING GENES IN EGYPTIAN WOMEN WITH BREAST CANCER.

  2017cites this paper
• Association between CYP17 T-34C rs743572 and breast cancer risk

  2017cites this paper
• Prevalence of COMT Val158Met polymorphism in Eastern UP population.

  2017cites this paper
• Associations of CYP1A1 gene polymorphisms and risk of breast cancer in Indian women: a meta-analysis

  2015influential citation
• association between the cOMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies

  2015cites this paper
• Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers.

  2015cites this paper
• Association of CYP1A1 and CYP2E1 gene polymorphisms with prostate cancer in a Lebanese population

  2015influential citation
• Sulfotransferase SULT1A1 Arg213His Polymorphism with Cancer Risk: A Meta-Analysis of 53 Case-Control Studies

  2014cites this paper
• Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case-control studies.

  2014cites this paper
• Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population

  2014cites this paper
• Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective

  2014influential citation
• Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case-control studies.

  2014cites this paper
• Sulfotransferase genetic variation: from cancer risk to treatment response

  2013cites this paper
• Clinical, cytogenetic and CYP1A1 exon-1 gene mutation analysis of Beedi workers in Vellore region, Tamil Nadu.

  2013cites this paper
• Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis

  2012cites this paper
• SULT1A1 Arg213His Polymorphism, Smoked Meat, and Breast Cancer Risk: A Case–Control Study and Meta-Analysis

  2012cites this paper
• Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls

  2012influential citation
• CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.

  2011cites this paper
• Cross-Talk Between One-Carbon Metabolism and Xenobiotic Metabolism: Implications on Oxidative DNA Damage and Susceptibility to Breast Cancer

  2011cites this paper
• The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects

  2010cites this paper
• Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects

  2010cites this paper
• CYP1A1, smoking and venous thromboembolism

  2010cites this paper
• No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

  2010cites this paper
• Oncotargets and Therapy Dovepress Dovepress Association between the Comt Val158met Polymorphism and Risk of Cancer: Evidence from 99 Case–control Studies

  year unknowncites this paper